least expensive glp 1 for weight loss Risky off-brand GLP-1 drugs become affordable option with history of safety issues 👩🏻‍⚕️Weight loss support just got

The workup is a real one: HbA1c, fasting glucose, a comprehensive metabolic panel for kidney and liver function, a lipid panel, and a TSH, plus history-driven markers

69% have been using the medication for fewer than two years and 53% expect to discontinue use in less than two more years 77% who had discontinued a GLP-1 medication said they were satisfied with the weight loss they experienced, but 90% were on the drug for less than one year Primary barriers to continued use: 76% note side effects

Specific actions of GLP-1 receptor agonists and DPP4 inhibitors for the treatment of pancreatic beta-cell impairments in type 2 diabetes

By reflecting the in vitro-data of these peptides some questions inevitably arise

Masumura Y, Kobayashi A, Yamazaki N

Eligible Medicare patients may now explore access through the Medicare GLP-1 Bridge Program for Wegovy or Zepbound